Iconic Therapeutics starts phase II trial of hI-con1 in choroidal neovascularization Feb. 20, 2015 No Comments
Midatech Pharma reports preclinical data on OpsiSporin sustained-release treatment for uveitis Feb. 20, 2015 No Comments
Cell Cure initiates phase I/II study of OpRegen in patients with dry AMD and geographic atrophy Feb. 20, 2015 No Comments
FDA approves Lucentis for diabetic retinopathy in patients with diabetic macular edema Feb. 9, 2015 No Comments
Ayoxxa and SERI collaborate on protein multiplexing technology platform for ophthalmology Feb. 6, 2015 No Comments
RSS